The overall average of five-year survival rate for women who contract breast cancer is around 86% for those whose disease has not metastasized. That means, 86% of the women who contract it survive for at least five years. But even that fairly high number is just an overall average. The numbers are even better for some categories. Those numbers depend on the stage at which the cancer is detected and treated.
As soon as you tell people you’re thinking of quitting smoking, it seems everybody knows someone who stopped recently. and that you should try the stop smoking program that they used. The problem is what works for one person won’t necessarily work for you.
INTRODUCTION: Colon cancer is cancer of the large intestine which is the lower part of your digestive system. It is the 2nd leading cause of cancer deaths in the United States, and is the leader of cancer deaths among non-smokers.
Lung cancer occurs when abnormal cells begin to reproduce and attack the tissues of the lungs.
That’s the plain and simple explanation. Here’s a short expansion: in its normal life, a cell will grow, divide, proliferate and then die, all the while meeting the needs of your body. When one or more of these cells […]
Cancer occurs because of damage to the genes responsible for cell growth and repair. This lack of cellular regeneration can lead to a host of problems and inevitably cancer.
The following is a basic over view of the classifications used in determining the different types of carcinogens:
Chemical:
These can be any number of substances, including but […]
Cancer treatment isn’t something you can do on your own. You need a physician’s help in order to survive, and that is a medical fact. However, some patients benefit from alternative cancer treatments that treat the body, mind and spirit.
Surviving cancer requires mental and physical strength. Unfortunately, a big side effect of common cancer treatments […]
In July, 2008, the pharmaceutical company Hollis-Eden announced the start of initial phase trials of the drug Apoptone, used in the treatment of late-stage prostate cancer patients for whom hormone therapy and at least one round of chemotherapy have proved ineffective.
Several months prior in April, 2008, Dr. Eva Corey from the University of Washington, presented […]
Skin cancer represents the most commonly diagnosed malignancy, surpassing lung, breast, colorectal and prostate cancer. Tumors develop primarily on areas of sun-exposed skin, including the scalp, face, lips, ears, neck, chest, arms and hands, and on the legs in women. Contrary to popular conception, skin cancer affects people of all skin tones, including those with […]
In July, 2008, British researchers claimed to have won a major victory for prostate cancer treatment. According to recently release reports, a new drug, abiraterone, may be used to treat as many as 80% of patients suffering from advanced forms of prostate cancer.
Researchers worldwide involved in the treatment of prostate cancer are cautiously optimistic, and […]
A recent study has revealed a racial disparity in prostate cancer treatment of patients in the U.S.
The study, conducted in 2007 and reported in the Journal of Urology earlier this year, was led by Dr. Kathryn E. Richert-Boe, of Kaiser Permanente Northwest in Portland, Oregon. It’s objectives were to determine whether differences existed in […]
